Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab™) for a first-in-human phase 1 clinical trial

N Lengkeek; M Roberts; T Pham; S Wissmeuller; D Campbell; B Walsh; Q Truong; I Greguric; J Wong; C Chandler; A Winthorpe; R Sheth; M Calvi; A Bowan; A Hawes

Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab™) for a first-in-human phase 1 clinical trial

N Lengkeek, M Roberts, T Pham, S Wissmeuller, D Campbell, B Walsh, Q Truong, I Greguric, J Wong, C Chandler, A Winthorpe, R Sheth, M Calvi, A Bowan, A Hawes

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	13
Number of pages	1
Journal	Internal Medicine Journal
Volume	48
Issue number	S3
Publication status	Published - Apr 2018
Externally published	Yes
Event	Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (48th : 2018) - Melbourne, Australia Duration: 21 Apr 2018 → 24 Apr 2018

Cite this

@article{15ccfa031eb24d0290b25e95093a8009,

title = "Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab{\texttrademark}) for a first-in-human phase 1 clinical trial",

author = "N Lengkeek and M Roberts and T Pham and S Wissmeuller and D Campbell and B Walsh and Q Truong and I Greguric and J Wong and C Chandler and A Winthorpe and R Sheth and M Calvi and A Bowan and A Hawes",

year = "2018",

month = apr,

language = "English",

volume = "48",

pages = "13",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley & Sons",

number = "S3",

note = "Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (48th : 2018) ; Conference date: 21-04-2018 Through 24-04-2018",

}

TY - JOUR

T1 - Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab™) for a first-in-human phase 1 clinical trial

AU - Lengkeek, N

AU - Roberts, M

AU - Pham, T

AU - Wissmeuller, S

AU - Campbell, D

AU - Walsh, B

AU - Truong, Q

AU - Greguric, I

AU - Wong, J

AU - Chandler, C

AU - Winthorpe, A

AU - Sheth, R

AU - Calvi, M

AU - Bowan, A

AU - Hawes, A

PY - 2018/4

Y1 - 2018/4

UR - http://doi.org/10.1111/imj.13801

M3 - Meeting abstract

SN - 1444-0903

VL - 48

SP - 13

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - S3

T2 - Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (48th : 2018)

Y2 - 21 April 2018 through 24 April 2018

ER -

Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab™) for a first-in-human phase 1 clinical trial

Other files and links

Cite this